Evidence map›Paper›PMID 38940301›Full record

ArticleImmunotherapy2024

Immunotherapy with γδ T-cells: the future is there.

Dieter Kabelitz, Zhinan Yin

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dieter KabelitzInstitute of Immunology, Christian-Albrechts-University & University Hospital Schleswig-Holstein Campus Kiel, Kiel, 24105, Germany.ORCID 0000-0002-4160-7103
Zhinan YinGuangdong Provincial Key Laboratory of Tumor Interventional Diagnosis & Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital affiliated with Jinan University, Jinan University, Zhuhai, 519000, China.ORCID 0000-0001-6524-8777

Funding

Deutsche Forschungsgemeinschaft Ka 502/19-3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ImmunotherapyReceptors, Antigen, T-Cell, gamma-deltaAnimalsHumansImmunotherapy, AdoptiveIntraepithelial LymphocytesNeoplasmsT-LymphocytesReceptors, Antigen, T-Cell, gamma-deltaadoptive cell therapybispecific T-cell engagerchimeric antigen receptordelta one T-cellsDOTimmunotherapyphosphoantigenvitamin C, γδ T-cells

Identifiers

PMID38940301
PMCPMC11421294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.